María Del Mar Tormo Díaz

33PUBLICATIONS
181CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Medical mycologyNanomedicineMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Nov 04, 2026
Temporal Trends in Real-World Outcomes With CPX-351 in Secondary/High-Risk Acute Myeloid Leukemia: A PETHEMA Study.

|Oct 14, 2026
Rapid molecular screening of adult AML: Experience from the Spanish CETLAM cooperative group.

|Oct 08, 2026
Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy.

|Oct 06, 2026
Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

|Aug 31, 2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

|Jun 11, 2026
Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.

Pageof 6

Frequent Collaborators

12 joint publications

Pau Montesinos

11 joint publications

David Martínez-Cuadrón

10 joint publications

Teresa Del Bernal Del Castillo

9 joint publications

Juan Miguel Bergua-Burgues